Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Debt to Equity (2018 - 2025)

Volitionrx filings provide 10 years of Debt to Equity readings, the most recent being -$0.19 for Q4 2025.

  • On a quarterly basis, Debt to Equity fell 19.18% to -$0.19 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.19, a 19.18% decrease, with the full-year FY2025 number at -$0.19, down 19.18% from a year prior.
  • Debt to Equity hit -$0.19 in Q4 2025 for Volitionrx, down from -$0.16 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.18 in Q3 2022 to a low of -$1.23 in Q1 2023.
  • Median Debt to Equity over the past 5 years was -$0.19 (2025), compared with a mean of -$0.13.
  • The widest YoY moves for Debt to Equity: up 793.65% in 2022, down 810.32% in 2022.
  • Volitionrx's Debt to Equity stood at $0.17 in 2021, then tumbled by 810.32% to -$1.23 in 2022, then skyrocketed by 54.91% to -$0.55 in 2023, then soared by 71.39% to -$0.16 in 2024, then dropped by 19.18% to -$0.19 in 2025.
  • The last three reported values for Debt to Equity were -$0.19 (Q4 2025), -$0.16 (Q3 2025), and -$0.19 (Q2 2025) per Business Quant data.